サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1737087

ヘルスケアロジスティクスの世界市場規模：サービス別、製品タイプ別、地域範囲別および予測

Global Healthcare Logistics Market Size By Service (Pharmaceutical Products, Medical Devices), By Product Type (Transportation, Warehousing), By Geographic Scope And Forecast

出版日
ページ情報
英文 202 Pages
納期
2～3営業日
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.76円
ヘルスケアロジスティクスの世界市場規模：サービス別、製品タイプ別、地域範囲別および予測
出版日: 2025年05月08日
発行: Verified Market Research
ページ情報: 英文 202 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

ヘルスケアロジスティクスの市場規模と予測

ヘルスケアロジスティクスの市場規模は、2024年に848億8,000万米ドルと評価され、2026～2032年にかけてCAGR 9.68%で成長し、2032年には1,793億1,000万米ドルに達すると予測されます。

ヘルスケアロジスティクスは、医療用品、機器、薬、臓器、組織、さらには個人を適切な場所、時間、状態に移動させるための計画、管理、調整を行う複雑なシステムです。ヘルスケアロジスティクスは、従来型ロジスティクスとは異なり、特殊な取り扱いと正確な配達時間が必要な、生命にかかわる製品を扱う。

この特殊なセグメントは、ファーストマイル、ミドルマイル、ラストマイルの3段階に分けることができます。ファーストマイルは、医薬品をメーカーから流通拠点まで輸送すること。ミドルマイルは、これらの商品を病院、クリニック、薬局に届けることに重点を置きます。ラストマイルは、医薬品や機器が必要に応じて患者に直接届けられることを保証するものです。

効率的なヘルスケアロジスティクスは、患者の安全と幸福を保証するために不可欠です。病院やクリニックが患者を効率的に治療するために十分な物資を確保することができるのです。特にクリティカルケアに必要な医薬品のタイムリーな配達は、生死を分けるかもしれません。さらに、温度の影響を受けやすい医薬品やワクチンは、効能を維持するために適切に保管・輸送されなければなりません。

ヘルスケアロジスティクスは、このような必要不可欠な機能だけでなく、研究開発にも不可欠です。臨床検査材料や生物学的サンプルの移動が容易になり、医療の進歩が早まる。さらに、強固なロジスティクスシステムは、血液バンク、臓器提供プログラム、緊急対応措置の処理にも不可欠です。

ヘルスケアロジスティクスの世界市場力学

世界のヘルスケアロジスティクス市場を形成している主要市場力学は以下の通りです。

主要市場促進要因

医薬品と医療機器に対する需要の高まり：世界の医薬品・医療機器セグメントの成長にはいくつかの要因が寄与しています。ヘルスケアのニーズが高まる高齢化社会は、慢性疾患の増加と相まって、医薬品や最新の医療機器に対する需要を押し上げています。さらに、医療研究開発の進歩が新薬や新技術の導入につながり、市場拡大の原動力となっています。

技術の進歩：人工知能（AI）、ブロックチェーン、モノのインターネット（IoT）などの先端技術の組み合わせが、ヘルスケアロジスティクスに変革をもたらしつつあります。人工知能を搭載したソリューションは、在庫管理を改善し、需要の変動を予測し、配送ルートを合理化することができます。ブロックチェーン技術は、サプライチェーン全体の透明性とトレーサビリティを向上させ、製品の真正性を確保し、偽造を減少させています。

コスト効率と業務最適化の重視：ヘルスケアプロバイダや製薬会社は、優れたサービスレベルを維持しながらコストを削減する必要に迫られています。ロジスティクスオペレーションの最適化は、在庫管理の改善、無駄の削減、効果的な輸送オプションの提供によってコストを削減します。

戦略的パートナーシップとコラボレーション：ロジスティクス企業とヘルスケア企業は、戦略的パートナーシップや提携を結ぶことが増えています。こうした提携は、サードパーティサプライヤーのロジスティクス経験を活用し、サプライチェーンの弾力性、効率性、市場対応力を高めるものです。

主要課題

製品の完全性の確保とコールドチェーン管理の維持：ヘルスケアロジスティクス市場の大部分は、ワクチン、血液製剤、医薬品、生物学的サンプルなど、温度に敏感な製品を扱っています。わずかな温度変動であっても、これらの医薬品の有効性や有用性に影響を及ぼし、患者の健康に悪影響を及ぼす可能性があります。製造からポイントオブケアデリバリーまで、サプライチェーン全体で安定した理想的な温度を維持することは、依然として大きな課題です。

データセキュリティとプライバシーに関する懸念：ヘルスケアロジスティクスでは、医薬品、医療記録、保険情報など、患者の機密データを扱う必要があります。サイバーセキュリティの脅威は、このセクタにとって継続的な心配事であり、データ漏洩は悲惨な影響をもたらす可能性があります。強力なサイバーセキュリティ安全対策への投資、データ保護手順に関する従業員トレーニングの提供、厳格なデータプライバシー法の遵守は、機密情報を保護するために不可欠です。

ラストワンマイルの課題管理：「ラストワンマイル」、すなわち医療用品を患者の自宅や介護施設に直接配送することは、医療ロジスティクスプロバイダにとって独特の障害となります。地理的な分散、道路の混雑、多様な患者のニーズはすべて、配送時間とコストに大きな影響を与えます。ドローンの使用や地域の配送業者との協力など、創造的なラストマイル配送の代替手段を開発することは、これらの問題を克服するのに役立ちます。

労働力不足と運営コストの上昇：ヘルスケアロジスティクス事業は、他の多くの事業と同様、深刻な人手不足に見舞われています。デリケートな医療品の取り扱いに必要な経験を持つ有資格者を見つけるのは難しい可能性があります。この人手不足は、サプライチェーンにおける遅延、非効率、エラーを引き起こす可能性があります。

主要動向

技術の統合：モノのインターネット（IoT）、ブロックチェーン、人工知能（AI）などの先進技術は、サプライチェーンの効率性、透明性、安全性を向上させるために、ヘルスケアロジスティクスで急速に利用されつつあります。これらの技術は医薬品や医療機器のリアルタイム追跡を可能にし、在庫管理の改善や偽造品リスクの低減につながります。

コールドチェーンロジスティクス：バイオ医薬品やワクチンなど、温度に敏感な医療製品のニーズが高まるにつれ、先進的コールドチェーンロジスティクスソリューションの必要性も高まっています。コールドチェーンロジスティクスとは、製造から配送に至るまで、デリケートなヘルスケア製品の安全性を確保するための温度モニタリングシステムを備えた専用の保管・輸送施設です。

規制遵守と品質保証：厳しい規制、特に医薬品ロジスティクスにおける規制は、コンプライアンスと品質保証手順への投資の動機付けとなり続けています。企業は、適正流通規範（GDP）や医薬品サプライチェーン安全保障法（Drug Supply Chain Security Act）などの要件へのコンプライアンスを確保するため、先進的追跡・追跡技術に投資しています。

持続可能性への取り組み：環境の持続可能性は、ヘルスケアロジスティクスプロバイダにとって最優先事項となっています。サプライチェーン全体を通じて、二酸化炭素排出量の削減、廃棄物の排除、資源利用の最適化がますます重視されています。取り組みには、エコフレンドリー包装資材の使用、エネルギー効率の高い輸送手段、リサイクルプログラムなどがあります。

目次

第1章 世界のヘルスケアロジスティクス市場の導入

  • 市場の定義
  • 市場セグメンテーション
  • 調査スケジュール
  • 前提条件
  • 制限事項

第2章 VERIFIED MARKET RESEARCHの調査手法

  • データマイニング
  • データの三角測量
  • ボトムアップアプローチ
  • トップダウンアプローチ
  • 調査の流れ
  • 産業専門家による主要な洞察
  • データソース

第3章 エグゼクティブサマリー

  • 市場概要
  • エコロジーのマッピング
  • 絶対的収益機会
  • 市場の魅力
  • ヘルスケアロジスティクスの世界市場地域別分析
  • ヘルスケアロジスティクスの世界市場：製品タイプ別（100万米ドル）
  • ヘルスケアロジスティクスの世界市場：サービス別（100万米ドル）
  • 今後の市場機会
  • 世界市場内訳
  • 製品ライフライン

第4章 ヘルスケアロジスティクスの世界市場展望

  • 世界のヘルスケアロジスティクスの進化
  • 促進要因
    • 促進要因1
    • 促進要因2
  • 抑制要因
    • 抑制要因1
    • 抑制要因2
  • 機会
    • 機会1
    • 機会2
  • ポーターのファイブフォースモデル
  • バリューチェーン分析
  • 価格分析
  • マクロ経済分析

第5章 ヘルスケアロジスティクスの世界市場：製品タイプ別

  • 概要
  • 輸送
  • 保管

第6章 ヘルスケアロジスティクスの世界市場：サービス別

  • 概要
  • 医薬品
  • 医療機器

第7章 ヘルスケアロジスティクスの世界市場：地域別

  • 概要
  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • その他の欧州
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • その他のアジア太平洋
  • ラテンアメリカ
    • ブラジル
    • アルゼンチン
    • その他のラテンアメリカ
  • 中東・アフリカ
    • アラブ首長国連邦
    • サウジアラビア
    • 南アフリカ
    • その他の中東・アフリカ

第8章 世界のヘルスケアロジスティクス市場の競合情勢

  • 概要
  • 各社の市場ランキング
  • 企業の地域別フットプリント
  • 企業の産業別フットプリント
  • ACEマトリックス

第9章 企業プロファイル

  • Deutsche Post DHL
  • Kuehne+Nagel
  • UPS（Marken）
  • DB Group
  • FedEx
  • Air Canada
  • AmerisourceBergen Corp.
  • CEVA Logistics AG
  • Continental Cargo OU
  • United Parcel Service Inc
  • Emerald Freight Express
  • Cavalier Logistics Management II, Inc.
  • Alloga
  • KERRY LOGISTICS NETWORK LIMITED
  • NIPPON EXPRESS CO., LTD.
  • Propeller Health
  • Cohero Health Inc.
  • GlaxoSmithKline
  • AstraZeneca plc
  • Novartis AG
  • 3M Company
  • Teva Pharmaceuticals
  • Vectura Group
  • Cognita Labs, Llc

第11章 VERIFIED MARKET INTELLIGENCE

  • VERIFIED MARKET INTELLIGENCEについて
  • ダイナミックデータの可視化
目次
Product Code: 50205

Healthcare Logistics Market Size And Forecast

Healthcare Logistics Market size was valued at USD 84.88 Billion in 2024 and is projected to reach USD 179.31 Billion by 2032, growing at a CAGR of 9.68% from 2026 to 2032.

Healthcare logistics is a complicated system of planning, managing, and coordinating the movement of medical supplies, equipment, medications, organs, tissues, and even individuals to the appropriate location, time, and condition. Healthcare logistics, unlike conventional logistics, deals with life-critical products that necessitate particular handling and exact delivery times.

This particular field can be divided into three stages: the first mile, the middle mile, and the final mile. The first mile entails transporting medicinal items from manufacturers to distribution sites. The middle mile focuses on delivering these goods to hospitals, clinics, and pharmacies. Finally, the last mile guarantees that medications and equipment are delivered directly to patients, as needed.

Efficient healthcare logistics are critical to guaranteeing patient safety and well-being. It ensures that hospitals and clinics have enough supplies to treat patients efficiently. The timely delivery of medications, particularly those required for critical care, might be the difference between life and death. Additionally, temperature-sensitive medications and vaccines must be stored and transported properly to maintain their potency.

Beyond these essential functions, healthcare logistics is critical for research and development. It makes it easier to move clinical trial materials and biological samples, which speeds up medical advances. Furthermore, robust logistical systems are vital for handling blood banks, organ donation programs, and emergency response measures.

Global Healthcare Logistics Market Dynamics

The key market dynamics that are shaping the global healthcare logistics market include:

Key Market Drivers:

Rising Demand for Pharmaceuticals and Medical Devices: Several factors contribute to the globally pharmaceutical and medical device sectors' growth. An aging population with increasing healthcare needs, combined with the rise in chronic diseases, is driving up demand for drugs and modern medical equipment. Furthermore, advances in medical research & development are resulting in the introduction of novel medications and technologies, which is driving market expansion.

Technological Advancements: The combination of advanced technologies such as artificial intelligence (AI), blockchain, and the Internet of Things (IoT) is transforming healthcare logistics. Artificial intelligence-powered solutions can improve inventory management, forecast demand variations, and streamline delivery routes. Blockchain technology improves transparency and traceability throughout the supply chain, ensuring product authenticity and reducing counterfeiting.

Focus on Cost Efficiency and Operational Optimization: Healthcare providers and pharmaceutical companies face pressure to save costs while maintaining excellent service levels. Optimizing logistics operations saves money by improving inventory management, reducing waste, and providing effective transportation options.

Strategic Partnerships and Collaborations: Logistics and healthcare firms are increasingly forming strategic partnerships and collaborations. These alliances use third-party suppliers' logistical experience to increase supply chain resilience, efficiency, and market response.

Key Challenges:

Ensure Product Integrity and Maintain Cold Chain Management: A substantial percentage of the healthcare logistics market is concerned with temperature-sensitive products such as vaccines, blood products, medications, and biological samples. Even modest temperature fluctuations can have an impact on the effectiveness and usefulness of these medications, potentially causing negative health repercussions for patients. Maintaining a stable and ideal temperature across the supply chain, from manufacture to point-of-care delivery, is still a substantial challenges.

Data Security and Privacy Concerns: Healthcare logistics entails dealing with sensitive patient data such as medicines, medical records, and insurance information. Cybersecurity threats are an ongoing worry for the sector, and data breaches can have disastrous effects. Investing in strong cybersecurity safeguards, providing employee training on data protection procedures, and adhering to tight data privacy legislation is essential for protecting sensitive information.

Managing the "Last Mile" Challenge: The "last mile," or delivering medical supplies directly to patients' homes or care facilities, provides a unique set of obstacles for healthcare logistics providers. Geographic dispersion, road congestion, and diverse patient needs all have a substantial impact on delivery times and costs. Developing creative last-mile delivery alternatives, such as using drones or cooperating with local delivery firms, can help to overcome these issues.

Labor Shortages and Rising Operational Costs: The healthcare logistics business, like many others, is experiencing a serious manpower shortage. Finding qualified individuals with the necessary experience to handle delicate medical items might be difficult. This scarcity may cause delays, inefficiencies, and errors in the supply chain.

Key Trends:

Technology Integration: Advanced technologies such as the Internet of Things (IoT), blockchain, and artificial intelligence (AI) are rapidly being used in healthcare logistics to improve supply chain efficiency, transparency, and security. These technologies offer real-time tracking of pharmaceuticals and medical devices, resulting in improved inventory management and a reduced risk of counterfeit products.

Cold Chain Logistics: As the need for temperature-sensitive medical products such as biopharmaceuticals and vaccines grows, so does the need for advanced cold chain logistics solutions. This comprises specialized storage and transportation facilities outfitted with temperature-monitoring systems to ensure the safety of sensitive healthcare products from manufacturing to delivery.

Regulatory Compliance and Quality Assurance: Stringent regulatory regulations, particularly in pharmaceutical logistics, continue to motivate investments in compliance and quality assurance procedures. Companies are investing in advanced tracking and tracing technologies to ensure compliance with requirements such as Good Distribution Practices (GDP) and the Drug Supply Chain Security Act.

Sustainability Initiatives: Environmental sustainability has become a top priority for healthcare logistics providers. Throughout the supply chain, there is an increasing emphasis on lowering carbon emissions, eliminating waste, and optimizing resource use. Initiatives include the use of environmentally friendly packaging materials, energy-efficient modes of transportation, and recycling programs.

Global Healthcare Logistics Market Regional Analysis

Here is a more detailed regional analysis of the global healthcare logistics market:

North America:

North America is the largest global healthcare logistics market shareholder and is expected to grow at a CAGR of 7.75% over the forecast period. As the region's senior population grows, so does the incidence of chronic diseases, creating a demand for modern healthcare products and services, as well as improved medical help, to effectively treat the growing number of chronic disease patients.

As a result, there is a higher demand in this region for safe and secure transportation of drugs, medical equipment, and devices. According to a 2017 WTO assessment, the United States is the world's second-largest exporter of medical products, with reported exports totaling USD 116 billion.

The United States is also the world's second-largest ventilator exporter and third-largest exporter of personal protection equipment. The high tolerance and open-mindedness of North American citizens has supported healthcare institutions in creating and implementing an abundance of novel healthcare supply chain technology.

Europe:

Europe is expected to have a CAGR of 7.33% throughout the projection period. Current healthcare operations in Europe include value-based care, cost and margin issues, and increasing regulatory and compliance requirements.

These factors encourage healthcare manufacturers to adjust their supply chain operations in order to remain competitive in the logistics market and continue to assist healthcare providers by prioritizing patients.

Within the European medical device sector, there are two primary markets: mature (Western Europe) and emerging (East Europe). To meet Europe's demand for medical devices and pharmaceuticals, producers and logistics providers must supply low-cost logistical services.

Because of the gravity of the COVID situation, the European healthcare industry is working around the clock to assure a steady supply of necessary pharmaceuticals, medical supplies, and protective equipment. These rules have an immediate and severe influence on internationally connected supply chains, which drives regional market expansion.

Global Healthcare Logistics Market: Segmentation Analysis

The Global Healthcare Logistics Market is Segmented on the basis of Service, and Product Type And Geography.

Healthcare Logistics Market, By Service

  • Pharmaceutical Products
  • Medical Devices

Based on Service, the market is bifurcated into Pharmaceutical Products, and Medical Devices. The pharmaceutical products segment is currently dominating the Healthcare Logistics Market. It is expected to have the largest share throughout the forecast period due to the huge volume and value of pharmaceuticals shipped internationally. However, the medical device market is expected to be the fastest-growing segment. This expansion is linked to rising demand for complicated medical devices and increased use of minimally invasive procedures.

Healthcare Logistics Market, By Product Type

  • Transportation
  • Warehousing

Based on Product Type, the market is fragmented into Transportation and Warehousing. Transportation is currently the most dominant segment. This is due to the vital transportation of medical supplies, drugs, and equipment that must be delivered on time and often saves lives. Efficient transportation ensures that these products reach healthcare professionals rapidly. Warehousing is the fastest-growing segment. This growth is being driven by the increased use of complicated biological medications and the growing necessity for temperature-controlled storage. Warehousing businesses are creating specialized facilities to suit these rigorous standards.

Healthcare Logistics Market, By Geography

  • North America
  • Europe
  • Asia Pacific
  • Rest of the World
  • On the basis of Geography, the Global Healthcare Logistics Market is classified into North America, Europe, Asia Pacific, and the Rest of the world. North America currently dominates the market due to its strong pharmaceutical and biopharmaceutical sectors and high healthcare spending. They maintain a consistent growth rate. Europe has a sizable stake, with an emphasis on innovative technologies and regulations. Growth is likely to remain constant.

Key Players

The "Global Healthcare Logistics Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are Deutsche Post DHL, Kuehne + Nagel, UPS (Marken), DB Group, FedEx, Air Canada, AmerisourceBergen Corp., CEVA Logistics AG, Continental Cargo OU, United Parcel Service Inc, Emerald Freight Express, Cavalier Logistics Management II, Inc., Alloga, KERRY LOGISTICS NETWORK LIMITED, and NIPPON EXPRESS CO., LTD., Adherium, Propeller Health, Cohero Health Inc., GlaxoSmithKline, AstraZeneca plc, Novartis AG, 3M Company, Teva Pharmaceuticals, Vectura Group, Cognita Labs, Llc. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

  • Healthcare Logistics Market Recent Developments
  • In November 2022, Cardinal Health announced the debut of VelocareTM, a supply chain network and last-mile fulfillment solution capable of delivering necessary materials and services required for hospital-level care to patients' homes in one to two hours.
  • In August 2022, United Parcel Service Inc announced that it will buy Bomi Group, an Italian healthcare logistics company, to improve its ability to transport drugs that require cold storage.

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL HEALTHCARE LOGISTICS MARKET

  • 1.1 Market Definition
  • 1.2 Market Segmentation
  • 1.3 Research Timelines
  • 1.4 Assumptions
  • 1.5 Limitations

2 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

  • 2.1 Data Mining
  • 2.2 Data Triangulation
  • 2.3 Bottom-Up Approach
  • 2.4 Top-Down Approach
  • 2.5 Research Flow
  • 2.6 Key Insights from Industry Experts
  • 2.7 Data Sources

3 EXECUTIVE SUMMARY

  • 3.1 Market Overview
  • 3.2 Ecology Mapping
  • 3.3 Absolute Market Opportunity
  • 3.4 Market Attractiveness
  • 3.5 Global Healthcare Logistics Market Geographical Analysis (CAGR %)
  • 3.6 Global Healthcare Logistics Market, By Product Type (USD Million)
  • 3.7 Global Healthcare Logistics Market, By Service (USD Million)
  • 3.8 Future Market Opportunities
  • 3.9 Global Market Split
  • 3.10 Product Life Line

4 GLOBAL HEALTHCARE LOGISTICS MARKET OUTLOOK

  • 4.1 Global Healthcare Logistics Evolution
  • 4.2 Drivers
    • 4.2.1 Driver1
    • 4.2.2 Driver 2
  • 4.3 Restraints
    • 4.3.1 Restraint1
    • 4.3.2 Restraint 2
  • 4.4 Opportunities
    • 4.4.1 Opportunity1
    • 4.4.2 Opportunity 2
  • 4.5 Porters Five Force Model
  • 4.6 Value Chain Analysis
  • 4.7 Pricing Analysis
  • 4.8 Macroeconomic Analysis

5 GLOBAL HEALTHCARE LOGISTICS MARKET, BY PRODUCT TYPE

  • 5.1 Overview
  • 5.2 Transportation
  • 5.3 Warehousing

6 GLOBAL HEALTHCARE LOGISTICS MARKET, BY SERVICE

  • 6.1 Overview
  • 6.2 Pharmaceutical Products
  • 6.3 Medical devices

7 GLOBAL HEALTHCARE LOGISTICS MARKET, BY GEOGRAPHY

  • 7.1 Overview
  • 7.2 North America
    • 7.2.1 U.S.
    • 7.2.2 Canada
    • 7.2.3 Mexico
  • 7.3 Europe
    • 7.3.1 Germany
    • 7.3.2 U.K.
    • 7.3.3 France
    • 7.3.4 Italy
    • 7.3.5 Spain
    • 7.3.6 Rest of Europe
  • 7.4 Asia Pacific
    • 7.4.1 China
    • 7.4.2 Japan
    • 7.4.3 India
    • 7.4.4 Rest of Asia Pacific
  • 7.5 Latin America
    • 7.5.1 Brazil
    • 7.5.2 Argentina
    • 7.5.3 Rest of Latin America
  • 7.6 Middle-East and Africa
    • 7.6.1 UAE
    • 7.6.2 Saudi Arabia
    • 7.6.3 South Africa
    • 7.6.4 Rest of Middle-East and Africa

8 GLOBAL HEALTHCARE LOGISTICS MARKET COMPETITIVE LANDSCAPE

  • 8.1 Overview
  • 8.2 Company Market Ranking
  • 8.3 Key Developments
  • 8.4 Company Regional Footprint
  • 8.5 Company Industry Footprint
  • 8.6 ACE Matrix

9 COMPANY PROFILES

  • 9.1 Deutsche Post DHL
    • 9.1.1 Company Overview
    • 9.1.2 Company Insights
    • 9.1.3 Product Benchmarking
    • 9.1.4 Key Development
    • 9.1.5 Winning Imperatives
    • 9.1.6 Current Focus & Strategies
    • 9.1.7 Threat from Competition
    • 9.1.8 SWOT Analysis
  • 9.2 Kuehne + Nagel
    • 9.2.1 Company Overview
    • 9.2.2 Company Insights
    • 9.2.3 Product Benchmarking
    • 9.2.4 Key Development
    • 9.2.5 Winning Imperatives
    • 9.2.6 Current Focus & Strategies
    • 9.2.7 Threat from Competition
    • 9.2.8 SWOT Analysis
  • 9.3 UPS (Marken)
    • 9.3.1 Company Overview
    • 9.3.2 Company Insights
    • 9.3.3 Product Benchmarking
    • 9.3.4 Key Development
    • 9.3.5 Winning Imperatives
    • 9.3.6 Current Focus & Strategies
    • 9.3.7 Threat from Competition
    • 9.3.8 SWOT Analysis
  • 9.4 DB Group
    • 9.4.1 Company Overview
    • 9.4.2 Company Insights
    • 9.4.3 Product Benchmarking
    • 9.4.4 Key Development
    • 9.4.5 Winning Imperatives
    • 9.4.6 Current Focus & Strategies
    • 9.4.7 Threat from Competition
    • 9.4.8 SWOT Analysis
  • 9.5 FedEx
    • 9.5.1 Company Overview
    • 9.5.2 Company Insights
    • 9.5.3 Product Benchmarking
    • 9.5.4 Key Development
    • 9.5.5 Winning Imperatives
    • 9.5.6 Current Focus & Strategies
    • 9.5.7 Threat from Competition
    • 9.5.8 SWOT Analysis
  • 9.6 Air Canada
    • 9.6.1 Company Overview
    • 9.6.2 Company Insights
    • 9.6.3 Product Benchmarking
    • 9.6.4 Key Development
    • 9.6.5 Winning Imperatives
    • 9.6.6 Current Focus & Strategies
    • 9.6.7 Threat from Competition
    • 9.6.8 SWOT Analysis
  • 9.7 AmerisourceBergen Corp.
    • 9.7.1 Company Overview
    • 9.7.2 Company Insights
    • 9.7.3 Product Benchmarking
    • 9.7.4 Key Development
    • 9.7.5 Winning Imperatives
    • 9.7.6 Current Focus & Strategies
    • 9.7.7 Threat from Competition
    • 9.7.8 SWOT Analysis
  • 9.8 CEVA Logistics AG
    • 9.8.1 Company Overview
    • 9.8.2 Company Insights
    • 9.8.3 Product Benchmarking
    • 9.8.4 Key Development
    • 9.8.5 Winning Imperatives
    • 9.8.6 Current Focus & Strategies
    • 9.8.7 Threat from Competition
    • 9.8.8 SWOT Analysis
  • 9.9 Continental Cargo OU
    • 9.9.1 Company Overview
    • 9.9.2 Company Insights
    • 9.9.3 Product Benchmarking
    • 9.9.4 Key Development
    • 9.9.5 Winning Imperatives
    • 9.9.6 Current Focus & Strategies
    • 9.9.7 Threat from Competition
    • 9.9.8 SWOT Analysis
  • 9.10 United Parcel Service Inc
    • 9.10.1 Company Overview
    • 9.10.2 Company Insights
    • 9.10.3 Product Benchmarking
    • 9.10.4 Key Development
    • 9.10.5 Winning Imperatives
    • 9.10.6 Current Focus & Strategies
    • 9.10.7 Threat from Competition
    • 9.10.8 SWOT Analysis
  • 9.11 Emerald Freight Express
    • 9.11.1 Company Overview
    • 9.11.2 Company Insights
    • 9.11.3 Product Benchmarking
    • 9.11.4 Key Development
    • 9.11.5 Winning Imperatives
    • 9.11.6 Current Focus & Strategies
    • 9.11.7 Threat from Competition
    • 9.11.8 SWOT Analysis
  • 9.12 Cavalier Logistics Management II, Inc.
    • 9.12.1 Company Overview
    • 9.12.2 Company Insights
    • 9.12.3 Product Benchmarking
    • 9.12.4 Key Development
    • 9.12.5 Winning Imperatives
    • 9.12.6 Current Focus & Strategies
    • 9.12.7 Threat from Competition
    • 9.12.8 SWOT Analysis
  • 9.13 Alloga
    • 9.13.1 Company Overview
    • 9.13.2 Company Insights
    • 9.13.3 Product Benchmarking
    • 9.13.4 Key Development
    • 9.13.5 Winning Imperatives
    • 9.13.6 Current Focus & Strategies
    • 9.13.7 Threat from Competition
    • 9.13.8 SWOT Analysis
  • 9.14 KERRY LOGISTICS NETWORK LIMITED
    • 9.14.1 Company Overview
    • 9.14.2 Company Insights
    • 9.14.3 Product Benchmarking
    • 9.14.4 Key Development
    • 9.14.5 Winning Imperatives
    • 9.14.6 Current Focus & Strategies
    • 9.14.7 Threat from Competition
    • 9.14.8 SWOT Analysis
  • 9.15 NIPPON EXPRESS CO., LTD.
    • 9.15.1 Company Overview
    • 9.15.2 Company Insights
    • 9.15.3 Product Benchmarking
    • 9.15.4 Key Development
    • 9.15.5 Winning Imperatives
    • 9.15.6 Current Focus & Strategies
    • 9.15.7 Threat from Competition
    • 9.15.8 SWOT Analysis
  • 9.16 Propeller Health
    • 9.16.1 Company Overview
    • 9.16.2 Company Insights
    • 9.16.3 Product Benchmarking
    • 9.16.4 Key Development
    • 9.16.5 Winning Imperatives
    • 9.16.6 Current Focus & Strategies
    • 9.16.7 Threat from Competition
    • 9.16.8 SWOT Analysis
  • 9.17 Cohero Health Inc.
    • 9.17.1 Company Overview
    • 9.17.2 Company Insights
    • 9.17.3 Product Benchmarking
    • 9.17.4 Key Development
    • 9.17.5 Winning Imperatives
    • 9.17.6 Current Focus & Strategies
    • 9.17.7 Threat from Competition
    • 9.17.8 SWOT Analysis
  • 9.18 GlaxoSmithKline
    • 9.18.1 Company Overview
    • 9.18.2 Company Insights
    • 9.18.3 Product Benchmarking
    • 9.18.4 Key Development
    • 9.18.5 Winning Imperatives
    • 9.18.6 Current Focus & Strategies
    • 9.18.7 Threat from Competition
    • 9.18.8 SWOT Analysis
  • 9.19 AstraZeneca plc
    • 9.19.1 Company Overview
    • 9.19.2 Company Insights
    • 9.19.3 Product Benchmarking
    • 9.19.4 Key Development
    • 9.19.5 Winning Imperatives
    • 9.19.6 Current Focus & Strategies
    • 9.19.7 Threat from Competition
    • 9.19.8 SWOT Analysis
  • 9.20 Novartis AG
    • 9.20.1 Company Overview
    • 9.20.2 Company Insights
    • 9.20.3 Product Benchmarking
    • 9.20.4 Key Development
    • 9.20.5 Winning Imperatives
    • 9.20.6 Current Focus & Strategies
    • 9.20.7 Threat from Competition
    • 9.20.8 SWOT Analysis
  • 9.21 3M Company
    • 9.21.1 Company Overview
    • 9.21.2 Company Insights
    • 9.21.3 Product Benchmarking
    • 9.21.4 Key Development
    • 9.21.5 Winning Imperatives
    • 9.21.6 Current Focus & Strategies
    • 9.21.7 Threat from Competition
    • 9.21.8 SWOT Analysis
  • 9.22 Teva Pharmaceuticals
    • 9.22.1 Company Overview
    • 9.22.2 Company Insights
    • 9.22.3 Product Benchmarking
    • 9.22.4 Key Development
    • 9.22.5 Winning Imperatives
    • 9.22.6 Current Focus & Strategies
    • 9.22.7 Threat from Competition
    • 9.22.8 SWOT Analysis
  • 9.23 Vectura Group
    • 9.23.1 Company Overview
    • 9.23.2 Company Insights
    • 9.23.3 Product Benchmarking
    • 9.23.4 Key Development
    • 9.23.5 Winning Imperatives
    • 9.23.6 Current Focus & Strategies
    • 9.23.7 Threat from Competition
    • 9.23.8 SWOT Analysis
  • 9.24 Cognita Labs, Llc
    • 9.24.1 Company Overview
    • 9.24.2 Company Insights
    • 9.24.3 Product Benchmarking
    • 9.24.4 Key Development
    • 9.24.5 Winning Imperatives
    • 9.24.6 Current Focus & Strategies
    • 9.24.7 Threat from Competition
    • 9.24.8 SWOT Analysis

11. VERIFIED MARKET INTELLIGENCE

  • 11.1 About Verified Market Intelligence
  • 11.2 Dynamic Data Visualization